CAPRICOR THERAPEUTICS INC (CAPR)

US14070B3096 - Common Stock

5.5599  +0.32 (+6.1%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
25.18M2.55M240.00K310.00K1.01M
Operating Expenses
30.59M24.78M16.09M10.60M8.74M
Research and Development
17.15M13.93M8.47M5.06M5.14M
Selling, General, and Administrative Expenses
12.81M10.43M7.61M5.54M3.60M
Operating Income
-5.41M-22.23M-15.84M-10.29M-7.73M
Interest Income/Expense
1.73M520.00K60.00K30.00K90.00K
Other Income/Expense
67.66K190.00K550.00KN/AN/A
Non Recurring Items
-18.67M-7.47M-4.78M-3.40M0.00
Income Before Taxes
-22.29M-29.02M-20.02M-13.66M-7.64M
Net Income
-22.29M-29.02M-20.02M-13.66M-7.64M
EBITDA
-4.34M-21.70M-15.59M-10.15M-7.56M
 
Per Share Data
EPS Diluted Total Ops
-0.83-1.18-0.87-0.88-2.06
Non GAAP EPS
-0.87N/A-0.87-0.94-2.16
 
Statistics
Profit Margin
-88.52%-1138.04%-8341.67%-4406.45%-756.44%
Operating Profit Margin
-21.49%-871.76%-6600.00%-3319.35%-765.35%

All data in USD

Charts